Word is out about the identity of the corporate partner NxThera CEO Robert Paulson mentioned last week. It turns out it's American Medical Systems Inc. Minnetonka, Minnesota-based AMS (Nasdaq: AMMD) specializes in medical devices related to pelvic health. Shoreview, Minnesota-based NxThera is developing a thermal vapor prostate treatment -- technology that involves the same area of the body where American Medical Systems' expertise lies.
Uroplasty‘s performance finally “began to reflect the potential of the company” in the third quarter, CEO David Kaysen said Thursday during the company’s earnings call. The Minnetonka, Minnesota, device company ramped up its sales force, won over five new regional Medicare carriers, and boosted global sales by 14 percent to $3.5 million during the quarter, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Someone should tell CoreSpine Technologies that they are running out of Minnesota entrepreneurial awards to win. Two years after capturing the Minnesota Cup, the medical device startup based in Minnetonka, Minnesota, grabbed a Tekne Award for the state's top "small and growing" lifescience company.
Do you hear that? That's the sound of some mighty back-slapping at Uroplasty Inc.'s (NASDAQ:UPI) headquarters in Minnetonka, Minnesota. After winning Medicare reimbursement Wednesday for its urinary incontinence therapy, the company has seen its stock price jump more than 20 percent to around $5.35 per share.
UnitedHealth Group Inc. (NYSE:UNH) boosted its end-of-the-year profit forecast, thanks to a strong third quarter that blew through Wall Street estimates. The nation's largest private insurer, based in Minnetonka, Minnesota, said it now expects to earn $3.85 to $3.95 per share for the year, compared to its earlier estimate of $3.40 to $3.60 a share.
Dgimed Ortho Inc. is looking to raise $2 million from the sale of equity and warrants, according to documents filed with the Securities and Exchange Commission. The orthopedic startup, based in Minnetonka, Minnesota, has so far raised $550,000 of that amount.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Cardiac Concepts Inc. has raised $27.2 million from the sale of equity. The company, based in Minnetonka, Minnesota, is developing a pacemaker-like device that uses electricity to treat sleeping disorders.
What weak economy? UnitedHealth Group Inc. (NYSE: UNH) Tuesday boosted its annual profit forecast, thanks to a strong revenue growth across all of its businesses in the second quarter. The Minnetonka, Minnesota-based company, the nation’s largest private health insurer, said it now expects to earn $3.40 to $3.60 a share on revenue of $93 billion […]
In the not-too-distant-future, Dr. Jim Woodburn says, patients can reach their doctors on the phone. If that doesn’t sound too impressive, consider this: The doctor can literally see the patient, access medical histories, listen to heartbeats and check the eyes, ears, nose and throat — all from the other side of the country. “Telemedicine is […]
Impres Medical Inc. has raised $3 million from the sale of convertible debt and stock options, according to documents recently filed with the Securities and Exchange Commission. The startup, based in Minnetonka, Minn., is developing an implantable device to stop severe cramping (dysmenorrhea) and heavy bleeding (menorrhagia) in women by “deactivating” the endometrium, the inner […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Venture capitalists may be stingy these days but it seems what little money they’re willing to spend is going toward Anulex Technologies Inc. in Minnetonka, Minn. The company said Thursday that it raised $18 million in a Series E financing round. And Anulex still plans to raise at least $2 million more, said CFO David […]
Fresh off the launch of a next-generation version of its spinal-tissue repair device, Anulex Technologies has raised $3.8 million, according to a Securities and Exchange Commission filing. The funding comes in the form of debt and options, and was raised from 11 investors. Last month, Anulex began marketing a new version of its Xclose tissue-repair […]
Someday, in the not-so-distant future, EnteroMedics Inc. officials might look back at late 2009 and laugh. Or cry. That ultimately depends on whether the Food and Drug Administration ultimately approves or rejects the company’s groundbreaking Maestro device. Approval means enormous financial success, the only implantable neurostimulation device in the United States designed to treat obesity. […]
Here are some news/notes on a day in MedCity, Minnesota: Uroplasty Inc.’s stock price jumped 4.6 percent Tuesday after the company announced positive results from study of its incontinence treatment, according to the Minneapolis-St. Paul Business Journal. The movement comes after the Minnetonka-based medical device developer reported favorable results from a large study to be […]
Here are some news/notes from a day in MedCity, Minnesota: Mayo Clinic said Thursday that it returned to profitability in 2009, thanks mostly to large investment gains and expense control. The organization reported income of $333 million, a 4.4 percent operating margin, after breaking even in 2008. Mayo generated $7.6 billion, a 5 percent gain […]